Sarah diFrancesca


+1 212 479 6577

Sarah diFrancesca advises life sciences and healthcare companies on fraud and abuse, compliance and regulatory matters, including representing companies in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures. Her clients include late-stage pre-commercial and commercial pharmaceutical, medical device, biotechnology and clinical laboratory companies. She also has significant experience advising boards of directors, compliance committees and senior management in connection with internal investigations and compliance-related matters.

Download full bio


  • Zealand Pharma – $89 Million IPO 

  • Joint Effort By Cooley’s Bankruptcy and Healthcare Teams Successfully Represented Unsecured Creditors  

  • Aclaris Therapeutics IPO 

  • Bristol Meyers Enters Agreement with Five Prime 

  • Auspex Pharma $3.5 billion sale to Teva Pharma 

  • View all


  • St. Louis University, School of Law
    JD, 2005

  • Saint Louis University
    BA, cum laude, 2001

Admissions & Credentials

New York



  • American Health Lawyers Association

  • Food and Drug Law Institute

  • American Bar Association

Rankings & Accolades

    New York Metro: Rising Stars (2015)


+1 212 479 6577 office

55 Hudson Yards
New York, NY 10001-2157